Abzena Email Format
Pharmaceutical ManufacturingCalifornia, United States201-500 Employees
Abzena operates as an end-to-end CDMO and CRO focused on complex biologics and bioconjugates, providing support from discovery through commercial launch. It offers integrated programs or individual services designed to de-risk and accelerate development, enabling biotech and biopharma teams to advance their molecules. The company runs research, development, and cGMP facilities across San Diego, California; Bristol, Pennsylvania; and Cambridge, the United Kingdom, to support its work. Its client base includes biotech and biopharma firms seeking development and manufacturing support for complex biologics and bioconjugates. In the pharmaceutical manufacturing industry, Abzena positions itself as a comprehensive partner that adapts its approach to each project to move medicines forward. In 2025, Abzena expanded its abzelectpro CLD platform by launching two next-generation glutamine synthetase knockout cell line platforms.